Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raman R Gangakhedkar

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 26, 2018
Prevalence of CYP2D6*4 1934G/A polymorphism in Western Indian HIV patientsHariOm Singh, Sonam Lata, Raman R Gangakhedkar
BMJ Global Health|September 28, 2021
Understanding complexities in the uptake of indigenously developed rapid point-of-care diagnostics for containment of antimicrobial resistance in IndiaMonica Sharma, Raman R Gangakhedkar, Sanjay Bhattacharya, et al.
Current Molecular Medicine|April 12, 2019
Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicityHariOm Singh, Nayana Nambiar, Dharmesh Samani, et al.
The Journal of Gene Medicine|December 29, 2017
Impact of cellular restriction gene (TRIM5α, BST-2) polymorphisms on the acquisition of HIV-1 and disease progressionHariOm Singh, Dharmesh Samani, Manisha V Ghate, et al.
Molecular Genetics & Genomic Medicine|March 14, 2019
Occurrence of CYP2B6 516G>T polymorphism in patients with ARV-associated hepatotoxicityHariOm Singh, Sonam Lata, T N Dhole, et al.
The Journal of Gene Medicine|August 24, 2016
Genetic variation of MMP-2(-735 C>T) and MMP-9(-1562 C>T) gene in risk of development of HAND and severity of HANDHariOm Singh, Shruti D Marathe, Vijay Nema, et al.
The Indian Journal of Medical Research|May 5, 2020
Strategic planning to augment the testing capacity for COVID-19 in IndiaNivedita Gupta, Tarun Bhatnagar, Kiran Rade, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 4, 2017
CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severityHariOm Singh, Sonam Lata, Vijay Nema, et al.
The Indian Journal of Medical Research|April 23, 2020
Perspectives for repurposing drugs for the coronavirus disease 2019Sarah S Cherian, Megha Agrawal, Atanu Basu, et al.
AIDS Research and Human Retroviruses|January 26, 2019
Partial <i>pol</i> Sequences from Drug Naive HIV-2 Infected Individuals from Maharashtra, IndiaShubhankar S Ambike, Madhuri R Thakar, Ajit A Patil, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 26, 2018
Prevalence of CYP2D6*4 1934G/A polymorphism in Western Indian HIV patientsHariOm Singh, Sonam Lata, Raman R Gangakhedkar
BMJ Global Health|September 28, 2021
Understanding complexities in the uptake of indigenously developed rapid point-of-care diagnostics for containment of antimicrobial resistance in IndiaMonica Sharma, Raman R Gangakhedkar, Sanjay Bhattacharya, et al.
Current Molecular Medicine|April 12, 2019
Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicityHariOm Singh, Nayana Nambiar, Dharmesh Samani, et al.
The Journal of Gene Medicine|December 29, 2017
Impact of cellular restriction gene (TRIM5α, BST-2) polymorphisms on the acquisition of HIV-1 and disease progressionHariOm Singh, Dharmesh Samani, Manisha V Ghate, et al.
Molecular Genetics & Genomic Medicine|March 14, 2019
Occurrence of CYP2B6 516G>T polymorphism in patients with ARV-associated hepatotoxicityHariOm Singh, Sonam Lata, T N Dhole, et al.
The Journal of Gene Medicine|August 24, 2016
Genetic variation of MMP-2(-735 C>T) and MMP-9(-1562 C>T) gene in risk of development of HAND and severity of HANDHariOm Singh, Shruti D Marathe, Vijay Nema, et al.
The Indian Journal of Medical Research|May 5, 2020
Strategic planning to augment the testing capacity for COVID-19 in IndiaNivedita Gupta, Tarun Bhatnagar, Kiran Rade, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 4, 2017
CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severityHariOm Singh, Sonam Lata, Vijay Nema, et al.
The Indian Journal of Medical Research|April 23, 2020
Perspectives for repurposing drugs for the coronavirus disease 2019Sarah S Cherian, Megha Agrawal, Atanu Basu, et al.
AIDS Research and Human Retroviruses|January 26, 2019
Partial <i>pol</i> Sequences from Drug Naive HIV-2 Infected Individuals from Maharashtra, IndiaShubhankar S Ambike, Madhuri R Thakar, Ajit A Patil, et al.
Pageof 6